PRESS RELEASES

Nanospectra Biosciences Announces Enrollment Completion of Pivotal Study of AuroLase Therapy for Ablation of Prostate Tissue
November 2, 2021
Nanospectra Biosciences Raises First Tranche of Series B-1 Funding Led by Sirtex Medical
September 8, 2020
Nanospectra Biosciences Announces Four Additional Prestigious Trial Sites for Pivotal AuroLase Study
August 4, 2020

1
2
3
4

MEDIA

NEWS

March 25, 2020
UrologyTimes.com
Pivotal study to evaluate AuroLase therapy for prostate tissue ablation Learn more
October 11, 2019
BioTechniques.com
Could photothermal therapy become the ‘gold standard’ of cancer treatment? Learn more

1
2
3
4
5
6

BLOG HEADLINE

No items found